CN Stock MarketDetailed Quotes

Harbin Medisan Pharmaceutical (002900)

Watchlist
  • 13.11
  • +0.07+0.54%
Market Closed Jan 16 15:00 CST
4.15BMarket Cap-21.74P/E (TTM)

Harbin Medisan Pharmaceutical (002900) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
-30.75%580.65M
-21.08%413.12M
-16.93%205.03M
-4.58%1.13B
-9.10%838.53M
-17.86%523.44M
-27.86%246.82M
15.40%1.19B
21.08%922.46M
26.25%637.23M
Operating revenue
-30.75%580.65M
-21.08%413.12M
-16.93%205.03M
-4.58%1.13B
-9.10%838.53M
-17.86%523.44M
-27.86%246.82M
15.40%1.19B
21.08%922.46M
26.25%637.23M
Other operating revenue
----
25.88%42.4M
----
80.82%61.64M
----
91.66%33.68M
----
68.22%34.09M
----
77.35%17.57M
Total operating cost
-6.65%772.65M
-0.94%514.47M
-1.81%242.5M
-7.73%1.11B
-9.96%827.69M
-17.26%519.35M
-24.72%246.97M
13.15%1.2B
17.08%919.24M
21.84%627.69M
Operating cost
-17.75%337.23M
-1.25%237.29M
9.22%115.75M
15.99%552.57M
18.09%410.02M
7.99%240.28M
-16.82%105.98M
30.31%476.38M
29.77%347.21M
19.70%222.49M
Operating tax surcharges
3.56%9.21M
2.22%5.99M
0.75%3.06M
-19.18%11.89M
-24.29%8.89M
-29.60%5.86M
-30.70%3.03M
-6.05%14.71M
-1.63%11.74M
4.26%8.33M
Operating expense
-2.79%201.24M
-13.20%128.86M
-34.67%52.76M
-37.84%262.2M
-42.80%207.01M
-44.31%148.45M
-44.01%80.76M
-7.07%421.8M
2.14%361.87M
16.56%266.59M
Administration expense
17.50%148.76M
18.89%96.25M
22.00%47.78M
-3.69%169.85M
1.47%126.61M
-1.51%80.95M
14.61%39.16M
25.35%176.36M
34.71%124.78M
39.70%82.19M
Financial expense
3,555.24%12.78M
286.87%8.15M
165.74%4.38M
194.18%3.75M
91.01%-369.95K
-15.26%-4.36M
-182.51%-6.66M
36.81%-3.98M
14.46%-4.12M
-5.43%-3.78M
-Interest expense (Financial expense)
-14.00%19.51M
-10.11%13.53M
8.37%7.53M
35.34%30.98M
33.52%22.69M
34.20%15.05M
22.63%6.95M
1.29%22.89M
1.80%16.99M
6.82%11.22M
-Interest Income (Financial expense)
65.65%-6.55M
65.57%-5.18M
64.35%-3.3M
14.41%-23.04M
8.13%-19.07M
-5.41%-15.05M
-24.56%-9.25M
4.86%-26.91M
-0.89%-20.76M
-9.93%-14.27M
Research and development
-16.02%63.44M
-21.22%37.94M
-23.94%18.78M
-6.73%105.22M
-2.85%75.54M
-7.15%48.16M
22.06%24.69M
26.37%112.81M
22.44%77.76M
38.94%51.87M
Credit Impairment Loss
783.77%1.75M
433.43%369.05K
1,359.23%178.43K
-145.80%-1.27M
-76.61%198.51K
-135.68%-110.68K
-108.68%-14.17K
490.27%2.78M
14.75%848.74K
142.46%310.17K
Asset Impairment Loss
-4,378.31%-53.96M
-890.06%-11.04M
-924.93%-3.26M
-258.34%-1.31M
-217.49%-1.2M
-3.47%-1.12M
-113.74%-318.31K
-84.22%826.15K
-81.71%1.03M
-133.72%-1.08M
Other net revenue
-214.48%-34.17M
-117.58%-3.26M
-88.10%2.27M
-61.24%35M
-49.85%29.85M
-60.49%18.54M
-34.74%19.06M
27.16%90.31M
21.38%59.52M
37.65%46.94M
Fair value change income
-31.20%-9.77M
-66.90%-11.78M
-236.44%-5.03M
-209.46%-14.64M
-174.21%-7.45M
-156.11%-7.06M
-48.43%3.68M
-3.63%13.37M
269.83%10.03M
72.60%12.58M
Invest income
-34.75%16.63M
-29.65%11.64M
-32.71%5.39M
-25.69%32.42M
-25.05%25.49M
-32.84%16.55M
-25.78%8.02M
-5.07%43.62M
-6.04%34M
23.14%24.64M
-Including: Investment income associates
-35.91%14.62M
-31.22%10.33M
-39.77%4.11M
-16.94%29.74M
-12.98%22.82M
-15.02%15.02M
-16.28%6.83M
-15.47%35.81M
-19.67%26.22M
-0.26%17.68M
Asset deal income
-105.69%-17.68K
-123.58%-48.14K
-111.40%-19.65K
107.47%194.63K
111.93%310.68K
107.93%204.18K
237.99%172.32K
80.42%-2.61M
-352.45%-2.6M
-662.72%-2.57M
Other revenue
-10.59%11.18M
-24.55%7.61M
-33.47%5.01M
-39.32%19.61M
-22.85%12.51M
-22.84%10.08M
-33.86%7.52M
61.79%32.31M
24.86%16.21M
179.43%13.06M
Operating profit
-655.87%-226.18M
-562.11%-104.61M
-286.13%-35.21M
-21.53%62.01M
-35.15%40.69M
-59.91%22.64M
-56.32%18.91M
94.50%79.02M
143.02%62.74M
138.58%56.47M
Add:Non operating Income
-11.03%380.29K
-39.30%161.52K
-51.27%105K
-82.60%504.17K
-69.24%427.43K
-80.75%266.09K
544.71%215.49K
13.57%2.9M
-43.55%1.39M
148.42%1.38M
Less:Non operating expense
-95.77%58.21K
-96.32%50.38K
67,778.25%50.24K
358.81%2.5M
153.04%1.38M
184.90%1.37M
--74.01
-82.48%545.16K
-54.47%543.72K
2,979.20%480.97K
Total profit
-668.32%-225.86M
-585.29%-104.5M
-283.75%-35.15M
-26.26%60.01M
-37.50%39.74M
-62.47%21.53M
-55.85%19.13M
103.08%81.37M
134.77%63.59M
136.97%57.37M
Less:Income tax cost
-741.35%-14.38M
-311.62%-10.22M
-412.12%-5.36M
-55.46%5.03M
-63.40%2.24M
-135.78%-2.48M
-65.95%1.72M
-16.76%11.3M
-27.69%6.13M
27.20%6.94M
Net profit
-663.95%-211.48M
-492.53%-94.28M
-271.10%-29.8M
-21.55%54.98M
-34.74%37.5M
-52.37%24.02M
-54.52%17.41M
164.45%70.08M
208.73%57.46M
168.92%50.43M
Net profit from continuing operation
-663.95%-211.48M
-492.53%-94.28M
-271.10%-29.8M
-21.55%54.98M
-34.74%37.5M
-52.37%24.02M
-54.52%17.41M
164.45%70.08M
208.73%57.46M
168.92%50.43M
Less:Minority Profit
14.56%-2.63M
16.36%-1.89M
30.90%-950.34K
-3.17%-3.7M
-15.75%-3.08M
-28.09%-2.25M
-58.03%-1.38M
3.33%-3.58M
2.24%-2.66M
-0.33%-1.76M
Net profit of parent company owners
-614.61%-208.84M
-451.68%-92.39M
-253.52%-28.85M
-20.35%58.68M
-32.50%40.58M
-49.66%26.27M
-52.02%18.79M
143.86%73.66M
181.78%60.12M
154.50%52.19M
Earning per share
Basic earning per share
-607.69%-0.66
-462.50%-0.29
-250.00%-0.09
-20.83%0.19
-31.58%0.13
-52.94%0.08
-53.85%0.06
140.00%0.24
171.43%0.19
142.86%0.17
Diluted earning per share
-607.69%-0.66
-462.50%-0.29
-250.00%-0.09
-20.83%0.19
-31.58%0.13
-52.94%0.08
-53.85%0.06
140.00%0.24
171.43%0.19
142.86%0.17
Other composite income
Total composite income
-663.95%-211.48M
-492.53%-94.28M
-271.10%-29.8M
-21.55%54.98M
-34.74%37.5M
-52.37%24.02M
-54.52%17.41M
164.45%70.08M
208.73%57.46M
168.92%50.43M
Total composite income of parent company owners
-614.61%-208.84M
-451.68%-92.39M
-253.52%-28.85M
-20.35%58.68M
-32.50%40.58M
-49.66%26.27M
-52.02%18.79M
143.86%73.66M
181.78%60.12M
154.50%52.19M
Total composite income of minority owners
14.56%-2.63M
16.36%-1.89M
30.90%-950.34K
-3.17%-3.7M
-15.75%-3.08M
-28.09%-2.25M
-58.03%-1.38M
3.33%-3.58M
2.24%-2.66M
-0.33%-1.76M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Zhongxing Cai Guanghua Certified Public Accountants (Special General Partnership)
--
--
--
ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue -30.75%580.65M-21.08%413.12M-16.93%205.03M-4.58%1.13B-9.10%838.53M-17.86%523.44M-27.86%246.82M15.40%1.19B21.08%922.46M26.25%637.23M
Operating revenue -30.75%580.65M-21.08%413.12M-16.93%205.03M-4.58%1.13B-9.10%838.53M-17.86%523.44M-27.86%246.82M15.40%1.19B21.08%922.46M26.25%637.23M
Other operating revenue ----25.88%42.4M----80.82%61.64M----91.66%33.68M----68.22%34.09M----77.35%17.57M
Total operating cost -6.65%772.65M-0.94%514.47M-1.81%242.5M-7.73%1.11B-9.96%827.69M-17.26%519.35M-24.72%246.97M13.15%1.2B17.08%919.24M21.84%627.69M
Operating cost -17.75%337.23M-1.25%237.29M9.22%115.75M15.99%552.57M18.09%410.02M7.99%240.28M-16.82%105.98M30.31%476.38M29.77%347.21M19.70%222.49M
Operating tax surcharges 3.56%9.21M2.22%5.99M0.75%3.06M-19.18%11.89M-24.29%8.89M-29.60%5.86M-30.70%3.03M-6.05%14.71M-1.63%11.74M4.26%8.33M
Operating expense -2.79%201.24M-13.20%128.86M-34.67%52.76M-37.84%262.2M-42.80%207.01M-44.31%148.45M-44.01%80.76M-7.07%421.8M2.14%361.87M16.56%266.59M
Administration expense 17.50%148.76M18.89%96.25M22.00%47.78M-3.69%169.85M1.47%126.61M-1.51%80.95M14.61%39.16M25.35%176.36M34.71%124.78M39.70%82.19M
Financial expense 3,555.24%12.78M286.87%8.15M165.74%4.38M194.18%3.75M91.01%-369.95K-15.26%-4.36M-182.51%-6.66M36.81%-3.98M14.46%-4.12M-5.43%-3.78M
-Interest expense (Financial expense) -14.00%19.51M-10.11%13.53M8.37%7.53M35.34%30.98M33.52%22.69M34.20%15.05M22.63%6.95M1.29%22.89M1.80%16.99M6.82%11.22M
-Interest Income (Financial expense) 65.65%-6.55M65.57%-5.18M64.35%-3.3M14.41%-23.04M8.13%-19.07M-5.41%-15.05M-24.56%-9.25M4.86%-26.91M-0.89%-20.76M-9.93%-14.27M
Research and development -16.02%63.44M-21.22%37.94M-23.94%18.78M-6.73%105.22M-2.85%75.54M-7.15%48.16M22.06%24.69M26.37%112.81M22.44%77.76M38.94%51.87M
Credit Impairment Loss 783.77%1.75M433.43%369.05K1,359.23%178.43K-145.80%-1.27M-76.61%198.51K-135.68%-110.68K-108.68%-14.17K490.27%2.78M14.75%848.74K142.46%310.17K
Asset Impairment Loss -4,378.31%-53.96M-890.06%-11.04M-924.93%-3.26M-258.34%-1.31M-217.49%-1.2M-3.47%-1.12M-113.74%-318.31K-84.22%826.15K-81.71%1.03M-133.72%-1.08M
Other net revenue -214.48%-34.17M-117.58%-3.26M-88.10%2.27M-61.24%35M-49.85%29.85M-60.49%18.54M-34.74%19.06M27.16%90.31M21.38%59.52M37.65%46.94M
Fair value change income -31.20%-9.77M-66.90%-11.78M-236.44%-5.03M-209.46%-14.64M-174.21%-7.45M-156.11%-7.06M-48.43%3.68M-3.63%13.37M269.83%10.03M72.60%12.58M
Invest income -34.75%16.63M-29.65%11.64M-32.71%5.39M-25.69%32.42M-25.05%25.49M-32.84%16.55M-25.78%8.02M-5.07%43.62M-6.04%34M23.14%24.64M
-Including: Investment income associates -35.91%14.62M-31.22%10.33M-39.77%4.11M-16.94%29.74M-12.98%22.82M-15.02%15.02M-16.28%6.83M-15.47%35.81M-19.67%26.22M-0.26%17.68M
Asset deal income -105.69%-17.68K-123.58%-48.14K-111.40%-19.65K107.47%194.63K111.93%310.68K107.93%204.18K237.99%172.32K80.42%-2.61M-352.45%-2.6M-662.72%-2.57M
Other revenue -10.59%11.18M-24.55%7.61M-33.47%5.01M-39.32%19.61M-22.85%12.51M-22.84%10.08M-33.86%7.52M61.79%32.31M24.86%16.21M179.43%13.06M
Operating profit -655.87%-226.18M-562.11%-104.61M-286.13%-35.21M-21.53%62.01M-35.15%40.69M-59.91%22.64M-56.32%18.91M94.50%79.02M143.02%62.74M138.58%56.47M
Add:Non operating Income -11.03%380.29K-39.30%161.52K-51.27%105K-82.60%504.17K-69.24%427.43K-80.75%266.09K544.71%215.49K13.57%2.9M-43.55%1.39M148.42%1.38M
Less:Non operating expense -95.77%58.21K-96.32%50.38K67,778.25%50.24K358.81%2.5M153.04%1.38M184.90%1.37M--74.01-82.48%545.16K-54.47%543.72K2,979.20%480.97K
Total profit -668.32%-225.86M-585.29%-104.5M-283.75%-35.15M-26.26%60.01M-37.50%39.74M-62.47%21.53M-55.85%19.13M103.08%81.37M134.77%63.59M136.97%57.37M
Less:Income tax cost -741.35%-14.38M-311.62%-10.22M-412.12%-5.36M-55.46%5.03M-63.40%2.24M-135.78%-2.48M-65.95%1.72M-16.76%11.3M-27.69%6.13M27.20%6.94M
Net profit -663.95%-211.48M-492.53%-94.28M-271.10%-29.8M-21.55%54.98M-34.74%37.5M-52.37%24.02M-54.52%17.41M164.45%70.08M208.73%57.46M168.92%50.43M
Net profit from continuing operation -663.95%-211.48M-492.53%-94.28M-271.10%-29.8M-21.55%54.98M-34.74%37.5M-52.37%24.02M-54.52%17.41M164.45%70.08M208.73%57.46M168.92%50.43M
Less:Minority Profit 14.56%-2.63M16.36%-1.89M30.90%-950.34K-3.17%-3.7M-15.75%-3.08M-28.09%-2.25M-58.03%-1.38M3.33%-3.58M2.24%-2.66M-0.33%-1.76M
Net profit of parent company owners -614.61%-208.84M-451.68%-92.39M-253.52%-28.85M-20.35%58.68M-32.50%40.58M-49.66%26.27M-52.02%18.79M143.86%73.66M181.78%60.12M154.50%52.19M
Earning per share
Basic earning per share -607.69%-0.66-462.50%-0.29-250.00%-0.09-20.83%0.19-31.58%0.13-52.94%0.08-53.85%0.06140.00%0.24171.43%0.19142.86%0.17
Diluted earning per share -607.69%-0.66-462.50%-0.29-250.00%-0.09-20.83%0.19-31.58%0.13-52.94%0.08-53.85%0.06140.00%0.24171.43%0.19142.86%0.17
Other composite income
Total composite income -663.95%-211.48M-492.53%-94.28M-271.10%-29.8M-21.55%54.98M-34.74%37.5M-52.37%24.02M-54.52%17.41M164.45%70.08M208.73%57.46M168.92%50.43M
Total composite income of parent company owners -614.61%-208.84M-451.68%-92.39M-253.52%-28.85M-20.35%58.68M-32.50%40.58M-49.66%26.27M-52.02%18.79M143.86%73.66M181.78%60.12M154.50%52.19M
Total composite income of minority owners 14.56%-2.63M16.36%-1.89M30.90%-950.34K-3.17%-3.7M-15.75%-3.08M-28.09%-2.25M-58.03%-1.38M3.33%-3.58M2.24%-2.66M-0.33%-1.76M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Zhongxing Cai Guanghua Certified Public Accountants (Special General Partnership)------ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More